McNeil Recalls Children's, Infants' Tylenol Products
Bacterial Contamination Concerns Spur Action
By News Staff
9/24/2009
McNeil said it implemented the recall after the gram-negative bacterium Burkholderia cepacia was detected during examination of bulk raw material associated with one of the products' inactive ingredients. The company said no bacteria were detected in any finished product.
"The portion of raw material in which the bacteria was found was isolated and was not used in the production of any finished product," the company said in its letter. "However, it was decided, as a precaution, to recall all product that utilized any of the raw material manufactured at the same time as the raw material that tested positive for the bacteria."
The manufacturer also said B. cepacia infections could be potentially severe, especially in high-risk patients, such as those who have underlying pulmonary disease, cystic fibrosis or compromised immune systems.
McNeil is advising parents and caregivers who have given recalled product to their children and who have concerns to contact their physicians.
Lot numbers can be found on the bottom of product boxes and also on the labels that surround product bottles. Patients who have affected product can contact the company at (800) 962-5357, and McNeil will respond with a coupon for a new bottle.
Surgeon General Offers Vision for Healthy, Fit Nation
Salmonellosis Outbreak Spreads to 42 States
McNeil Recalls Contaminated OTC Medications
National Influenza Vaccination Week to Focus on H1N1 Efforts
FDA Initiative Targets Preventable Harms From Medications
MedImmune Recalls 13 Lots of Intranasal H1N1 Vaccine
Sanofi Pasteur Recalls Pediatric H1N1 Vaccine
Colorectal Cancer Diagnoses, Deaths Plummeting
U.S. Public Health Policies Undercut Economy, National Security
FP Holds Video Contest to Spread Hand Awareness Message
H1N1 Vaccine Demand High as Supplies Increase
USPSTF Chair Defends Task Force, Recommendations
FDA Advises Against Concomitant Use of Clopidogrel, Omeprazole
Recent Decline in U.S. Smoking Prevalence Stalls
USPSTF Revamps Breast Cancer Screening Recommendations
New Report Sounds 'Call to Revolutionize Chronic Pain Care'
AAFP Offers Guidance on FDA Tobacco Regulation
Focus Groups Reveal Physician Concerns About Comparative Effectiveness Research
Manufacturer Recalls Millions of Insulin Syringes
Second Grant to be Used for More Children's Healthy Lifestyles Books
AAFP, Others Reiterate Need for Flu Vaccines in Pregnant Women
Study Suggests Cost for Universal Coverage Misleading
FDA Warns of Adverse Events With Gentamicin Ophthalmic Ointment Use
AAFP, Other Organizations Urge Pregnant Women to Get Flu Vaccines
Physicians Should Recall Children in Need of Hib Booster Dose
FDA Rule
Label Changes Coming for OTC Pain, Fever Medications
(5/12/2009)
FDA Warns Against Using OTC Cough, Cold Meds in Young Children
Side Effects Can Be Life-threatening
(1/17/2008)








